114 related articles for article (PubMed ID: 1405346)
1. Uremic serum effects on peripheral blood mononuclear cell and purified T lymphocyte responses.
Donati D; Degiannis D; Raskova J; Raska K
Kidney Int; 1992 Sep; 42(3):681-9. PubMed ID: 1405346
[TBL] [Abstract][Full Text] [Related]
2. Accessory cell functions in mononuclear cell cultures uremic patients.
Ladefoged J; Langhoff E
Kidney Int; 1990 Jan; 37(1):126-30. PubMed ID: 2299798
[TBL] [Abstract][Full Text] [Related]
3. Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release.
Donati D; Degiannis D; Homer L; Gastaldi L; Raskova J; Raska K
Nephron; 1991; 58(3):268-75. PubMed ID: 1896091
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of calcium ionophore and phorbol ester-induced T-cell activation. Accessory cell requirement for T-cell activation.
Hashimoto S; Takahashi Y; Tomita Y; Hayama T; Sawada S; Horie T; McCombs CC; Michalski JP
Scand J Immunol; 1991 Apr; 33(4):393-403. PubMed ID: 2017664
[TBL] [Abstract][Full Text] [Related]
5. Activation-induced T cell apoptosis by monocytes from stem cell products.
Ino K; Ageitos AG; Singh RK; Talmadge JE
Int Immunopharmacol; 2001 Jul; 1(7):1307-19. PubMed ID: 11460311
[TBL] [Abstract][Full Text] [Related]
6. IL-2 responsiveness of lectin-induced lymphoblasts: soluble IL-2 receptor release and differential in vitro effects of immunosuppressants.
Hornung N; Raskova J; Raska K; Degiannis D
Int J Immunopharmacol; 1992 Jul; 14(5):753-60. PubMed ID: 1512072
[TBL] [Abstract][Full Text] [Related]
7. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
Elg SA; Hill RB; Heldman L; Ramakrishnan S
Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
[TBL] [Abstract][Full Text] [Related]
8. Release of sIL-2R alpha from and activation of native human peripheral blood mononuclear cells by recombinant IL-15.
Treiber-Held S; Stewart DM; Barraclough HA; Kurman CC; Nelson DL
Clin Immunol Immunopathol; 1996 Jul; 80(1):67-75. PubMed ID: 8674241
[TBL] [Abstract][Full Text] [Related]
9. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
Kunicka JE; Platsoucas CD
Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
[TBL] [Abstract][Full Text] [Related]
10. IL-2 regulation of soluble IL-2 receptor levels following thermal injury.
Teodorczyk-Injeyan JA; Sparkes BG; Lalani S; Peters WJ; Mills GB
Clin Exp Immunol; 1992 Oct; 90(1):36-42. PubMed ID: 1382903
[TBL] [Abstract][Full Text] [Related]
11. An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro.
Nelson DL; Rubin LA; Kurman CC; Fritz ME; Boutin B
J Clin Immunol; 1986 Mar; 6(2):114-20. PubMed ID: 3086363
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human large granular lymphocyte and T cell growth and function by recombinant interleukin 2: induction of interleukin 2 receptor and promotion of growth of cells with enhanced cytotoxicity.
Yamada S; Ruscetti FW; Overton WR; Herberman RB; Birchenall-Sparks MC; Ortaldo JR
J Leukoc Biol; 1987 Jun; 41(6):505-17. PubMed ID: 3110337
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of IL-2/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure.
Meier P; Dayer E; Ronco P; Blanc E
Clin Nephrol; 2005 Jan; 63(1):8-21. PubMed ID: 15678692
[TBL] [Abstract][Full Text] [Related]
14. Uremic serum inhibits monocyte-dependent, but not interleukin-2-dependent steps of T cell proliferation.
Dumann H; Meuer SC; Köhler H
Nephron; 1990; 56(2):162-5. PubMed ID: 2243571
[TBL] [Abstract][Full Text] [Related]
15. Altered gene transcription after burn injury results in depressed T-lymphocyte activation.
Horgan AF; Mendez MV; O'Riordain DS; Holzheimer RG; Mannick JA; Rodrick ML
Ann Surg; 1994 Sep; 220(3):342-51; discussion 351-2. PubMed ID: 8092900
[TBL] [Abstract][Full Text] [Related]
16. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 modulates the effects of interleukin 2 independent of IL-2 receptor binding.
Rigby WF; Hamilton BJ; Waugh MG
Cell Immunol; 1990 Feb; 125(2):396-414. PubMed ID: 2105168
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 2 receptor expression by T cells in human aging.
Orson FM; Saadeh CK; Lewis DE; Nelson DL
Cell Immunol; 1989 Dec; 124(2):278-91. PubMed ID: 2510938
[TBL] [Abstract][Full Text] [Related]
19. Signalling via the TCR/CD3 antigen receptor complex in uremia is limited by the receptors number.
Stachowski J; Pollok M; Burrichter H; Spithaler C; Baldamus CA
Nephron; 1993; 64(3):369-75. PubMed ID: 8101978
[TBL] [Abstract][Full Text] [Related]
20. Immunological studies in uremic and kidney transplanted patients.
Langhoff E
Dan Med Bull; 1989 Apr; 36(2):160-75. PubMed ID: 2651030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
